Showing results (1021-1030 of 2,735) with videos related to
Sort By:
Pageof 274
Pharmacogenomics|March 3, 2012
CDA deficiency as a possible culprit for life-threatening toxicities after cytarabine plus 6-mercaptopurine therapy: pharmacogenetic investigationsJoseph Ciccolini, Alexandre Evrard, Lithaty M'Batchi, et al.Pharmacogenomics|March 3, 2012
Regulation of gene expression in atherosclerosis: insights from microarray studies in monocytes/macrophagesJuan C Laguna, Marta AlegretPharmacogenomics|October 24, 2014
SULT4A1 haplotype: conflicting results on its role as a biomarker of antipsychotic responseDai Wang, Qingqin Li, Reyna Favis, et al.Pharmacogenomics|October 24, 2014
Genetic variation in platinating agent and taxane pathway genes as predictors of outcome and toxicity in advanced non-small-cell lung cancerJatinder Kaur Lamba, Brooke L Fridley, Taraswi M Ghosh, et al.Pharmacogenomics|October 24, 2014
Effect of UGT2B7 -900G>A (-842G>A; rs7438135) on morphine glucuronidation in preterm newborns: results from a pilot cohortMaja Matic, Elisabeth Norman, Anders Rane, et al.Pharmacogenomics|November 21, 2014
Genetic polymorphisms and response to medications for alcohol use disorders: a systematic review and meta-analysisDaniel E Jonas, Halle R Amick, Cynthia Feltner, et al.Pharmacogenomics|March 21, 2001
Automated protein modelling--the proteome in 3DM C Peitsch, T Schwede, N GuexPharmacogenomics|March 21, 2001
Accelerating discoveries in the proteome and genome with MALDI TOF MSP Kowalski, J StoerkerPharmacogenomics|March 21, 2001
Pharmacogenetic diagnostics of cytochrome P450 polymorphisms in clinical drug development and in drug treatmentJ Brockmöller, J Kirchheiner, C Meisel, et al.Pharmacogenomics|September 6, 2001
The pharmacogenetics of analgesia: toward a genetically-based approach to pain managementC M Flores, J S MogilPageof 274